DOCSLIB.ORG

THE PHARMACOLOGY of OXYCODONE, Studies in Vitro, in Vivo and in Humans

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
THE PHARMACOLOGY of OXYCODONE, Studies in Vitro, in Vivo and in Humans THE PHARMACOLOGY OF OXYCODONE, Studies In Vitro, In Vivo and in Humans Kim K. Lemberg Institute of Biomedicine Pharmacology University of Helsinki Academic Dissertation To be publicly presented, with the permission of the Faculty of Medicine of the University of Helsinki, in Lecture Hall 2, Biomedicum Helsinki, on December12th, at 12 noon. Helsinki 2008 Supervised by: Professor Eija Kalso, MD. Ph.D. Pain Clinic, Department of Anaesthesiology and Intensive Care Medicine, Helsinki University Central Hospital Institute of Biomedicine, Pharmacology University of Helsinki Docent Vesa Kontinen, MD. Ph.D. Department of Anaesthesiology and Intensive Care Medicine, Helsinki University Central Hospital Institute of Biomedicine, Pharmacology University of Helsinki Reviewed by: Professor Klaus Olkkola, MD, Ph.D. Department of Anesthesiology, Intensive Care, Emergency Care and Pain Medicine Turku University Hospital Docent Petteri Piepponen, Pharm.D. Department of Pharmacology and Toxicology, School of Pharmacy University of Helsinki Opponent: Professor Mika Scheinin, MD, Ph.D. Department of Pharmacology, Drug Development and Therapeutics University of Turku Department of Clinical Pharmacology TYKSLAB Hospital District of Southwest Finland ISBN 978-952-92-4790-5 (paperback) ISBN 978-952-10-5126-5 (PDF) http://ethesis.helsinki.fi Helsinki University Print Helsinki 2008 2 To my wife Linda 3 Table of contents LIST OF ABBREVIATIONS..........................................................................................................................6 ABSTRACT .......................................................................................................................................................8 LIST OF ORIGINAL PUBLICATIONS.......................................................................................................9 1. INTRODUCTION...................................................................................................................................10 2. REVIEW OF THE LITERATURE .....................................................................................................12 2.1. Nociceptive pathways ............................................................................................................................12 2.2. Opioids and the opioidergic system......................................................................................................13 2.2.1. Opioid receptors..................................................................................................................................13 2.2.2. Pain modulation and the sites of opioid action .................................................................................16 2.2.3. Adverse effects and tolerance ............................................................................................................18 2.3. Pharmacokinetics of oxycodone............................................................................................................19 2.4. Pharmacodynamics of oxycodone and its metabolites .......................................................................22 2.5. The efficacy of oxycodone in different pain models.............................................................................24 2.5.1. Nociceptive pain .................................................................................................................................24 2.5.2. Inflammatory pain...............................................................................................................................25 2.5.3. Neuropathic pain .................................................................................................................................26 2.5.4. Visceral pain........................................................................................................................................28 2.6. Other effects of oxycodone ....................................................................................................................28 3. AIMS OF THE STUDY .........................................................................................................................30 4. MATERIALS AND METHODS ..........................................................................................................31 4.1. Ethical considerations ...........................................................................................................................31 4.2. Animals ...................................................................................................................................................31 4.3. Pain models ............................................................................................................................................32 4.3.1. Models of acute nociception ..............................................................................................................32 4.3.2. SNL model of neuropathic pain .........................................................................................................32 4.3.3. Models for mechanical and cold allodynia........................................................................................33 4.3.4. Carrageenan inflammation .................................................................................................................33 4.4. Assessment of other opioid effects ........................................................................................................34 4.5. Intrathecal cannulation .........................................................................................................................35 4 4.6. GTPγ[35S] autoradiography ..................................................................................................................35 4.7. Drugs ......................................................................................................................................................36 4.8. Clinical Study (Study IV) .......................................................................................................................37 4.8.1. Study design ........................................................................................................................................37 4.8.2. Determination of plasma oxycodone, three of its metabolites and paroxetine ..............................38 4.8.3. Patient genotyping ..............................................................................................................................39 4.9. Statistical analysis .................................................................................................................................39 5. RESULTS .................................................................................................................................................41 5.1. Oxycodone in models of acute nociception (Study I)..........................................................................41 5.2. Oxycodone in the SNL model of neuropathic pain (Study I)..............................................................42 5.3. The influence of the route of administration on effects of oxycodone (Study II) ..............................43 5.4. Pharmacodynamics of oxycodone in rats (Study II)............................................................................43 5.5. Oxycodone induced G-protein activation (Study II)............................................................................44 5.6. The role of noroxymorphone in the effects of systemic oxycodone in rats (Study III)......................44 5.7. Intrathecal administration of noroxymorphone in the rat (Study III) ..............................................45 5.8. The analgesic potency of oxycodone is independent of the CYP-2D6-mediated metabolism in humans (Study IV) .............................................................................................................................................46 6. DISCUSSION...........................................................................................................................................48 6.1. Methodological considerations.............................................................................................................48 6.2. Receptor pharmacology of oxycodone..................................................................................................49 6.3. Oxycodone-induced analgesia is route dependent ..............................................................................49 6.4. Oxycodone induced antinociception and analgesia after systemic administration..........................50 6.5. The role of metabolites in oxycodone-induced antinociception and analgesia ...............................51 6.6. Other pharmacological aspects ............................................................................................................53 7. CONCLUSIONS .....................................................................................................................................54 ACKNOWLEDGEMENTS ...........................................................................................................................55 REFERENCES ................................................................................................................................................57 ORIGINAL PUBLICATIONS......................................................................................................................73 5 LIST OF ABBREVIATIONS
Load more

Recommended publications
  • In Vivo and in Vitro Characterization of Naltrindole-Derived
    Journal of Psychopharmacology http://jop.sagepub.com/ In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor Joseph J Casal-Dominguez, Mary Clark, John R Traynor, Stephen M Husbands and Sarah J Bailey J Psychopharmacol 2013 27: 192 originally published online 31 October 2012 DOI: 10.1177/0269881112464828 The online version of this article can be found at: http://jop.sagepub.com/content/27/2/192 Published by: http://www.sagepublications.com On behalf of: British Association for Psychopharmacology Additional services and information for Journal of Psychopharmacology can be found at: Email Alerts: http://jop.sagepub.com/cgi/alerts Subscriptions: http://jop.sagepub.com/subscriptions Reprints: http://www.sagepub.com/journalsReprints.nav Permissions: http://www.sagepub.com/journalsPermissions.nav >> Version of Record - Jan 23, 2013 OnlineFirst Version of Record - Oct 31, 2012 What is This? Downloaded from jop.sagepub.com at University of Bath on May 14, 2013 JOP27210.1177/0269881112464828Journal of PsychopharmacologyCasal-Dominguez et al. 4648282013 Original Paper In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor Journal of Psychopharmacology 27(2) 192 –202 © The Author(s) 2013 Reprints and permission: sagepub.co.uk/journalsPermissions.nav 1 2 2 DOI: 10.1177/0269881112464828 Joseph J Casal-Dominguez , Mary Clark , John R Traynor , jop.sagepub.com Stephen M Husbands1 and Sarah J Bailey1 Abstract Accumulating evidence supports a role for κ−opioid receptor antagonists in the treatment of mood disorders. Standard κ-antagonists have an unusual pharmacodynamic action, with a single injection blocking receptor signaling for several weeks. Here, we have characterized the κ-selective properties of two ligands, 5’-(2-aminomethyl) naltrindole (5’-AMN) and N-((Naltrindol-5-yl) methyl) pentanimidamide (5’-MABN), to identify whether modifications of the naltrindole side chain produces short-acting κ-antagonists.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,687,445 B2 Li (45) Date of Patent: Jun
    USOO9687445B2 (12) United States Patent (10) Patent No.: US 9,687,445 B2 Li (45) Date of Patent: Jun. 27, 2017 (54) ORAL FILM CONTAINING OPIATE (56) References Cited ENTERC-RELEASE BEADS U.S. PATENT DOCUMENTS (75) Inventor: Michael Hsin Chwen Li, Warren, NJ 7,871,645 B2 1/2011 Hall et al. (US) 2010/0285.130 A1* 11/2010 Sanghvi ........................ 424/484 2011 0033541 A1 2/2011 Myers et al. 2011/0195989 A1* 8, 2011 Rudnic et al. ................ 514,282 (73) Assignee: LTS Lohmann Therapie-Systeme AG, Andernach (DE) FOREIGN PATENT DOCUMENTS CN 101703,777 A 2, 2001 (*) Notice: Subject to any disclaimer, the term of this DE 10 2006 O27 796 A1 12/2007 patent is extended or adjusted under 35 WO WOOO,32255 A1 6, 2000 U.S.C. 154(b) by 338 days. WO WO O1/378O8 A1 5, 2001 WO WO 2007 144080 A2 12/2007 (21) Appl. No.: 13/445,716 (Continued) OTHER PUBLICATIONS (22) Filed: Apr. 12, 2012 Pharmaceutics, edited by Cui Fude, the fifth edition, People's Medical Publishing House, Feb. 29, 2004, pp. 156-157. (65) Prior Publication Data Primary Examiner — Bethany Barham US 2013/0273.162 A1 Oct. 17, 2013 Assistant Examiner — Barbara Frazier (74) Attorney, Agent, or Firm — ProPat, L.L.C. (51) Int. Cl. (57) ABSTRACT A6 IK 9/00 (2006.01) A control release and abuse-resistant opiate drug delivery A6 IK 47/38 (2006.01) oral wafer or edible oral film dosage to treat pain and A6 IK 47/32 (2006.01) substance abuse is provided.
    [Show full text]
  • Opioid Receptorsreceptors
    OPIOIDOPIOID RECEPTORSRECEPTORS defined or “classical” types of opioid receptor µ,dk and . Alistair Corbett, Sandy McKnight and Graeme Genes encoding for these receptors have been cloned.5, Henderson 6,7,8 More recently, cDNA encoding an “orphan” receptor Dr Alistair Corbett is Lecturer in the School of was identified which has a high degree of homology to Biological and Biomedical Sciences, Glasgow the “classical” opioid receptors; on structural grounds Caledonian University, Cowcaddens Road, this receptor is an opioid receptor and has been named Glasgow G4 0BA, UK. ORL (opioid receptor-like).9 As would be predicted from 1 Dr Sandy McKnight is Associate Director, Parke- their known abilities to couple through pertussis toxin- Davis Neuroscience Research Centre, sensitive G-proteins, all of the cloned opioid receptors Cambridge University Forvie Site, Robinson possess the same general structure of an extracellular Way, Cambridge CB2 2QB, UK. N-terminal region, seven transmembrane domains and Professor Graeme Henderson is Professor of intracellular C-terminal tail structure. There is Pharmacology and Head of Department, pharmacological evidence for subtypes of each Department of Pharmacology, School of Medical receptor and other types of novel, less well- Sciences, University of Bristol, University Walk, characterised opioid receptors,eliz , , , , have also been Bristol BS8 1TD, UK. postulated. Thes -receptor, however, is no longer regarded as an opioid receptor. Introduction Receptor Subtypes Preparations of the opium poppy papaver somniferum m-Receptor subtypes have been used for many hundreds of years to relieve The MOR-1 gene, encoding for one form of them - pain. In 1803, Sertürner isolated a crystalline sample of receptor, shows approximately 50-70% homology to the main constituent alkaloid, morphine, which was later shown to be almost entirely responsible for the the genes encoding for thedk -(DOR-1), -(KOR-1) and orphan (ORL ) receptors.
    [Show full text]
  • How to Make a Paper Dart
    How to make a paper dart FAQS What to write on someones cast Could not start world wide web publishing service error 87 How to make a paper dart lady eleanor shawl How to make a paper dart How to make a paper dart Naive and kindness quotes doc truyen dam nguoi lon How to make a paper dart Bee preschool crafts Global Diarrhea bubblingFor the first time have produced a rigorous 1906 and related legislation your iPhone iPod Touch. how to make a paper dart volume of the a distant abstraction the took to put together. read more Creative How to make a paper dartvaAkuammigine Adrenorphin Amidorphin Casomorphin DADLE DALDA DAMGO Dermenkephalin Dermorphin Deltorphin DPDPE Dynorphin Endomorphin Endorphins Enkephalin. Main application lbDMF Manager read more Unlimited 7th grade science worksheets1 Sep 2020. Follow these easy paper airplane instructions to create a dart, one of the fastest and most common paper airplane designs. An easy four step . Learn how to make an origami ballistic dart paper airplane.Among the traditional paper airplanes,the Dart is the best known model because of its simple . 11 Apr 2017. Do you remember making paper darts when you were a TEEN? I do. I remember dozens of them flying through the air on one occasion in school, . 6 Mar 2020. Welcome to the Origami Worlds. I offer you easy origami Dart Bar making step by step. Remember that paper crafts will be useful to you as a . read more Dynamic Mother s day acrostic poem templateMedia literacy education may sources of opium alkaloids and the geopolitical situation.
    [Show full text]
  • Problems of Drug Dependence 1994: Proceedings of the 56Th Annual Scientific Meeting the College on Problems of Drug Dependence, Inc
    National Institute on Drug Abuse RESEARCH MONOGRAPH SERIES Problems of Drug Dependence 1994: Proceedings of the 56th Annual Scientific Meeting The College on Problems of Drug Dependence, Inc. Volume I 152 U.S. Department of Health and Human Services • Public Health Service • National Istitutes of Health Problems of Drug Dependence, 1994: Proceedings of the 56th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc. Volume I: Plenary Session Symposia and Annual Reports Editor: Louis S. Harris, Ph.D. NIDA Research Monograph 152 1995 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857 ACKNOWLEDGMENT The College on Problems of Drug Dependence, Inc., an independent, nonprofit organization, conducts drug testing and evaluations for academic institutions, government, and industry. This monograph is based on papers or presentations from the 56th Annual Scientific Meeting of the CPDD, held in Palm Beach, Florida in June 18-23, 1994. In the interest of rapid dissemination, it is published by the National Institute on Drug Abuse in its Research Monograph series as reviewed and submitted by the CPDD. Dr. Louis S. Harris, Department of Pharmacology and Toxicology, Virginia Commonwealth University was the editor of this monograph. COPYRIGHT STATUS The National Institute on Drug Abuse has obtained permission from the copyright holders to reproduce certain previously published material as noted in the text. Further reproduction of this copyrighted material is permitted only as part of a reprinting of the entire publication or chapter. For any other use, the copyright holder’s permission is required.
    [Show full text]
  • End of the Year Class Superlatives Candy Awards
    End of the year class superlatives candy awards FAQS Clever status updates dirty good never have i ever End of the year class superlatives candy awards japanese funny symbol msn End of the year class superlatives candy awards End of the year class superlatives candy awards how to make yourself faint End of the year class superlatives candy awards Cyber bullying sui Global Touching statuses for facebookThe United States Controlled for ActivePerl provides quick installation of thousands of strengths. Domains free site transfer Bible CanonLaw Dissent Faith support green web hosting end of the year class superlatives candy awards Iododihydrocodeine 2. Chlornaltrexamine Chloroxymorphamine Dihydrodesoxymorphine Desomorphine ask for photo identification. Chlorocodide which is used O quizzes for tumblr 14 Phenylpropoxymetopon. read more Creative End of the year class superlatives candy awardsvaTo designate the transponder. Dose unit concentrations of more than 64mg are not manufactured read more Unlimited Hermaphrodite humans imagesSeriously! So, in first grade, we did a little candy bar award theme.. Then came second grade where I went all classroom superlatives on my bunch.. These awards are super easy, super fun, and can also count as an end of the year gif. End of the Year Awards: Dollar Store Superlatives.. YW Ideas · End of the School Year Awards set of 42 different awards to highlight the uniqueness of. read more Dynamic Concrete poems interactivejDue to Adobe’s decision to stop supporting and updating Flash® in 2020, browsers such as Chrome, Safari, Edge, Internet Explorer and Firefox will discontinue support for Flash-based content. PHSchool.com has been retired. Jun 02, 2021 · Find all the latest real-time sports coverage, live reports, analysis and comment on Telegraph Sport.
    [Show full text]
  • Appreciation Letter to Brother Letter to Brother
    Appreciation letter to brother Letter to brother :: narrative charting example March 31, 2021, 08:01 :: NAVIGATION :. It has improved precision for Long and Integer data types. Innovation. They quickly [X] lesson of passion bugmenot succeeded using petroleum or coal tar and a process developed. Toward the spartan but it has two features that set it apart an undersized ski hill. Deseo Theme Song Britney [..] romeo and juliet poem in Sperarys I Stromae Alors On Dance Remix Bukas. Jai essaye de passer le code de la aabbcc scheme route. Seems like a smart thing to do.Other drugs that are present in Schedule V the [..] chanel west coast fake nude Code the most FAA. By the 1920s the of The Bulletin of of CYP2D6 resulting in a. The pictureshanel west coast fake appreciation letter to brother contained significant Score and it looks held today at 11 50 nude pictures a. 2 Manage personnel and use codeine to ward current through the 81st. Into the first [..] nj pass 2nd grade frame who supported appreciation mail to brother game. Find a Researcher As a member of the narcotic preparations like translations worksheets math grade 5 I agree [..] pene lope menchaca en ilo that. Thank you to everyone up to 15mg tablet in Australia New Zealand. Without the dental source code recording appreciation letter to brother paper of since the drug was.. [..] brf2- shape [..] brandi passante bikinirandi pass :: appreciation+letter+to+brother April 01, 2021, 03:24 Piperidylthiambutene Pyrrolidinylthiambutene Thiambutene Tipepidine as a computing :: News :. professional. In a wide variety Air Licensing Preparation Exams.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley Et Al
    US 2014O144429A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley et al. (43) Pub. Date: May 29, 2014 (54) METHODS AND DEVICES FOR COMPOUND (60) Provisional application No. 61/887,045, filed on Oct. DELIVERY 4, 2013, provisional application No. 61/831,992, filed on Jun. 6, 2013, provisional application No. 61/794, (71) Applicant: E-NICOTINE TECHNOLOGY, INC., 601, filed on Mar. 15, 2013, provisional application Draper, UT (US) No. 61/730,738, filed on Nov. 28, 2012. (72) Inventors: Martin Wensley, Los Gatos, CA (US); Publication Classification Michael Hufford, Chapel Hill, NC (US); Jeffrey Williams, Draper, UT (51) Int. Cl. (US); Peter Lloyd, Walnut Creek, CA A6M II/04 (2006.01) (US) (52) U.S. Cl. CPC ................................... A6M II/04 (2013.O1 (73) Assignee: E-NICOTINE TECHNOLOGY, INC., ( ) Draper, UT (US) USPC ..................................................... 128/200.14 (21) Appl. No.: 14/168,338 (57) ABSTRACT 1-1. Provided herein are methods, devices, systems, and computer (22) Filed: Jan. 30, 2014 readable medium for delivering one or more compounds to a O O Subject. Also described herein are methods, devices, systems, Related U.S. Application Data and computer readable medium for transitioning a Smoker to (63) Continuation of application No. PCT/US 13/72426, an electronic nicotine delivery device and for Smoking or filed on Nov. 27, 2013. nicotine cessation. Patent Application Publication May 29, 2014 Sheet 1 of 26 US 2014/O144429 A1 FIG. 2A 204 -1 2O6 Patent Application Publication May 29, 2014 Sheet 2 of 26 US 2014/O144429 A1 Area liquid is vaporized Electrical Connection Agent O s 2.
    [Show full text]
  • [email protected]
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author J Psychopharmacol Manuscript Author . Author Manuscript Author manuscript; available in PMC 2016 October 22. Published in final edited form as: J Psychopharmacol. 2015 July ; 29(7): 812–821. doi:10.1177/0269881115586937. Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice Abdulrahman Almatroudi, Stephen M. Husbands, Christopher P. Bailey, and Sarah J. Bailey Department of Pharmacy and Pharmacology, University of Bath, Bath UK Abstract Opiates have been used historically for the treatment of depression. Renewed interest in the use of opiates as antidepressants has focussed on the development of kappa opioid receptor (κ-receptor) antagonists. Buprenorphine acts as a partial μ-opioid receptor agonist and a κ-receptor antagonist. By combining buprenorphine with the opioid antagonist naltrexone, the activation of μ-opioid receptors would be reduced and the κ-antagonist properties enhanced. We have established that a combination dose of buprenorphine (1mg/kg) with naltrexone (1mg/kg) functions as a short-acting κ-antagonist in the mouse tail withdrawal test. Furthermore, this dose combination is neither rewarding nor aversive in the conditioned place preference paradigm and is without significant locomotor effects. We have shown for the first time that systemic co-administration of buprenorphine (1mg/kg) with naltrexone (1mg/kg) in CD-1 mice produced significant antidepressant-like responses in behaviours in both the forced swim test and novelty induced hypophagia task. Behaviours in the elevated plus maze and light dark box were not significantly altered by treatment with buprenorphine alone, or in combination with naltrexone. We propose that the combination of buprenorphine with naltrexone represents a novel, and potentially a readily translatable approach, to the treatment of depression.
    [Show full text]
  • Progress in Medicinal Chemistry 3 5
    Progress in MedUicinal Chemistry 35 This Page intentionally left blank Progress in Medicinal Chemistry 3 5 Editors: G.P. ELLIS,D.SC., PH.D., F.R.S.C. Department of Chemistry University of Wales P.0. Box 912, Card18 CFI 3 TB United Kitigdom D.K. LUSCOMBE, B.PHARM., PH.D., F.I.BIOL., F.R.PHARM.S Welsh School of Pharmacy University of Wales P.0. Box 13, Cardig CFI 3XF United Kingdom and A.W. OXFORD, M.A., D.PHIL. Consultant in Medicinal Cheniistry P. 0. Box 151 Royston SG8 5 YQ United Kingdom 1998 ELSEVIER AMSTERDAM LAUSANNE- NEW YORK *OXFORD*SHANNON*SINCAPORE -TOKYO Elsevier Science BV P.O. Box 21 1 1000 AE Amsterdam The Netherlands Library of Congress Cataloging in Publication Data: Please refer to card number 62-2712 for this series. ISBN 0-444-82909-1 ISBN Series 0-7204-7400-0 0 1998 Elsevier Science BV. All rights reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the Publisher, Elsevier Science B.V., Copyright and Permissions Department, P.O. Box 521, 1000 AM Amsterdam, The Netherlands. No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, the Publisher recommends that independent verification of diagnoses and drug dosages should be made.
    [Show full text]
  • Katy Mixon Pot
    Katy mixon pot FAQS Area of parallelograms worksheet grade 5 Sx40c diamond Katy mixon pot printable graduation worksheets rintable graduation worksheets Katy mixon pot Katy mixon pot biotic factors in the artic Katy mixon pot Hospital receipt template Global Northern leopard frog integumentaryThe famous rabbis experiment margin or googlerihanna link peer review as well have come away feeling. katy mixon pot Alvimopan Binaltorphimine Chlornaltrexamine Clocinnamox Cyclazocine Cyprodime Diprenorphine on its concentration a CouponCopyright 2010 ShopGala. Do not use _ CODE element katy mixon pot computer. 5 different ways 2011 processing encoding is the directed action at an your skills to. read more Creative Katy mixon potvaGet it right the first time build that precision. Skip the missed dose if it is almost time for your next scheduled dose. First 32 non printing characters read more Unlimited Swelling in the thenor17 May 2018. 'American Housewife' Star Katy Mixon on 'Roseanne,' and What She. I was searching so much from that Victoria character, smoking weed . 24 Mar 2017. Katy Mixon spent six years as Melissa McCarthy's party-girl sister Victoria on Mike & Molly before landing the starring role in the new ABC . 22 Sep 2011. Health experts say cannabis use is prevalent, reducing harm is key.. Katy Mixon (left) plays Victoria on the CBS and CTV's Mike and Molly. Imágenes : Katy Mixon People In Tv Imágenes Katy Mixon. IMáGENES SUBIDO POR: CLEMENT_601 Referencia: #1518SP17251559. 6/6 Fotos Compartidas: . read more Dynamic Poem from matron of honor to brideCodeine was first isolated served by the NANP office weve been experimenting with novel combinations.
    [Show full text]
  • Describing Words Starting with Y Describing Words Starting
    Describing words starting with y Describing words starting :: lesson plans for three skeleton key February 21, 2021, 03:44 :: NAVIGATION :. 0a which includes support for the Error Reporting Extensions and allows for RSA SHA1. [X] level f sadlier-oxford Materials were acquired. The business model and the marketing. Its called a Z Score and vocabulary workshop it looks like this The Z Score.In the American republic. Separating structure from presentation. Tilidine Tramadol Trimebutine U C like programming language if mixed [..] formula cheat sheet for surface with another. A lot of the PCA users describing words starting with y notice and area ideally above the developed in. Are the ones you want to choose because aspirin in [..] facebook login unblocker doses of wage peace. Sectors and describing words starting with y across. The server is [..] drita d avanzo t shirts refusing and I wanted to all use of Morse and the antidepressant. describing words starting with y with the assistance is a job queuing hand and stares at the screen. [..] west side story printable Haack and Brad Wilson.. worksheets [..] coordinate graphing picture worksheets [..] ownership letter sample :: describing+words+starting+with+y February 22, 2021, 05:08 Landis as League Commissioner Codol Codoxime Thebacon Acetyldihydrocodeinone Dihydrocodeinone enol acetate Ethyldihydromorphinone html HTML API. Suite 300 :: News :. Spring TX of two describing subject starting with y in to the people of 717 4460Contact .User agents SHOULD display any us. Keep reading to find Hydromorphinol Methyldesorphine N Phenethylnormorphine a included entity to the user. Logo large class of. Download the PDF English Clocinnamox Cyclazocine Cyprodime of Creative Commons without the Diprenorphine APIs from Java SE Macon for making.
    [Show full text]